These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15619320)

  • 1. Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents.
    Granillo GA; van Dijk LC; McFadden EP; Serruys PW
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):23-7. PubMed ID: 15619320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short and long-term outcomes of two drug eluting stents in bifurcation lesions.
    Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; Wu Y; Dai J
    Chin Med J (Engl); 2007 Feb; 120(3):183-6. PubMed ID: 17355818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
    Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifurcation stenting with drug eluting stents: illustration of the crush technique.
    Sianos G; Vaina S; Hoye A; Serruys PW
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):839-45. PubMed ID: 16649229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience.
    Burzotta F; Gwon HC; Hahn JY; Romagnoli E; Choi JH; Trani C; Colombo A
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):75-82. PubMed ID: 17585382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
    J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries.
    Valgimigli M; Malagutti P; Rodriguez Granillo GA; Tsuchida K; Garcia-Garcia HM; van Mieghem CA; Van der Giessen WJ; De Feyter P; de Jaegere P; Van Domburg RT; Serruys PW
    Am Heart J; 2006 Nov; 152(5):896-902. PubMed ID: 17070153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
    J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left main coronary artery stenosis treatment with two paclitaxel-eluting stents in a patient with cardiac allograft vasculopathy.
    Martínez-Ríos MA; Méndez-Ortíz A; Gaspar J; Barragán-García R; Fernández-de-la-Reguera G; González-Quesada CJ
    Arch Cardiol Mex; 2008; 78(4):407-12. PubMed ID: 19205549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
    Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
    Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The OstialPro positioning system for a renal artery stenosis.
    Igbokidi O; Jovin IS
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):430-2. PubMed ID: 20049958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of complex stenoses involving renal artery bifurcations with use of drug-eluting stents.
    Misra S; Sturludottir M; Mathew V; Bjarnason H; McKusick M; Iyer VK
    J Vasc Interv Radiol; 2008 Feb; 19(2 Pt 1):272-8. PubMed ID: 18341961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
    Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW
    Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry.
    Vaquerizo B; Lefèvre T; Darremont O; Silvestri M; Louvard Y; Leymarie JL; Garot P; Routledge H; de Marco F; Unterseeh T; Zwahlen M; Morice MC
    Circulation; 2009 May; 119(17):2349-56. PubMed ID: 19380624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
    Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crush stenting in treating coronary bifurcate lesions: paclitaxel eluting stents versus sirolimus eluting stents.
    Chen SL; Zhang JJ; Ye F; Chen YD; Zhu ZS; Lin S; Tian NL; Liu ZZ; Fang WY; Sun XW; Hu DY; Kwan TW
    Chin Med J (Engl); 2008 Mar; 121(6):528-33. PubMed ID: 18364140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.